BetterLife Pharma Inc. (BETRF)

OTCMKTS · Delayed Price · Currency is USD
0.0531
+0.0081 (18.00%)
Mar 6, 2026, 11:56 AM EST
-20.27%
Market Cap 9.58M
Revenue (ttm) n/a
Net Income (ttm) -1.32M
Shares Out 151.90M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,000
Average Volume 33,259
Open 0.0531
Previous Close 0.0450
Day's Range 0.0531 - 0.0531
52-Week Range 0.0276 - 0.0879
Beta 0.57
RSI 66.56
Earnings Date May 29, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange OTCMKTS
Ticker Symbol BETRF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.